Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 6 | 6 |
Avg. Estimate | 1.85 | 2.25 | 3.28 | 7.54 |
Low estimate | 1.85 | 2.25 | 2.4 | 5.6 |
High estimate | 1.85 | 2.25 | 4.28 | 11.77 |
Year ago EPS | 0.6 | 0.54 | 2.1 | 3.28 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 5 | 1 | 6 | 6 |
Avg. Estimate | 4.96B | 5.21B | 19.15B | 21.8B |
Low estimate | 4.81B | 5.21B | 18.98B | 20.95B |
High estimate | 5.09B | 5.21B | 19.25B | 22.24B |
Year ago sales | 4.41B | 4.6B | 16.91B | 19.15B |
Sales growth (year/est) | 12.40% | 13.40% | 13.20% | 13.90% |
Earnings history | 31/03/2023 | 30/06/2023 | 30/09/2023 | 31/12/2023 |
---|---|---|---|---|
Est. EPS | 1.21 | 2.33 | 2.07 | 1.52 |
Actual EPS | 0.6 | 0.54 | 0.97 | 0.41 |
Difference | -0.61 | -1.79 | -1.1 | -1.11 |
Surprise % | -50.40% | -76.80% | -53.10% | -73.00% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 1.85 | 2.25 | 3.28 | 7.54 |
7 days ago | 1.85 | 2.25 | 3.28 | 7.54 |
30 days ago | 1.85 | 2.25 | 3.25 | 7.54 |
60 days ago | 1.85 | 2.25 | 3.14 | 7.51 |
90 days ago | 1.85 | 2.25 | 3.32 | 7.51 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | 1 | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | HCG.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 208.30% | N/A | N/A | N/A |
Next qtr. | 316.70% | N/A | N/A | N/A |
Current year | 56.20% | N/A | N/A | N/A |
Next year | 129.90% | N/A | N/A | N/A |
Next 5 years (per annum) | 0.10% | N/A | N/A | N/A |
Past 5 years (per annum) | 6.30% | N/A | N/A | N/A |